CD4 and idiopathic pulmonary fibrosis: Most importantly, marked CD28 down-regulation on the peripheral CD4 T-cells of individual IPF patients is associated with a higher likelihood of their requiring lung transplantations or dying during the next year (Figure 5A), and these T-cell measures also seem to complement and enhance the prognostic utility of pulmonary physiologic testing (Figure 5B).